HERSH PATEL, MD: THE BOTHRA TRIAL, HOW DEFENSE ATTY LAWRENCE MARGOLIS EXPOSED DEA EXPERT PATEL AS A COMPLETE FRAUD

Pain physician Hersh Patel MD captured authoring fraudulent EMR note with “cut and paste” medical history. He documented a physical exam that never happened. Also documented advising patient about risks of opioids, risks,alternatives etc. etc that never actually happened.  Hersh Patel MD, straight out of his pain fellowship training, telling elderly folks that they can be arrested for taking their physician-prescribed FDA approved opioid

 

HERSH DINESH PATEL MD., FALSE UNO-FALSE OMNIBUS “WHEN A GOVERNMENT WITNESS LIES THEY MUST LOSE THEIR MEDICAL LICENSE: A COMPLAINT BEFORE DELAWARE MEDICAL BOARD

 

THE MYTH OF MORPHINE MILLIGRAM EQUIVALENT DAILY DOSE: NABARUN DASGUPTA et al. DOES THE MATH

Dr. Naburun Dasgupta informative lecture on the falsehood of the Morphine Milligram Equivalent and calls into question the Prosecution of healthcare providers by the US Attorney General and the Department of Justice and DEA in the use of Narcotic Analgesic Medications (Opioids)

reported by norman j clement rph., dds

THE MYTH OF MORPHINE MILLIGRAM EQUIVALENT DAILY DOSE

In 2016, the CDC issued its Guidelines for Prescribing Opioids for Chronic Pain Patients. In publishing the guidelines, the CDC explicitly stated that they were meant to be voluntary and “not prescriptive,” stating that healthcare practitioners knew their patients’ unique clinical situation and should weigh the potential risks and benefits when prescribing opioids. Many of its recommendations were based on what the CDC characterized as “Type 3” or “Type 4” evidence, which are categories of evidence that are less probative and carry a significant risk of inaccuracy. The guidelines thus came under significant criticism from many pain and addiction specialists for lacking a strong basis in the evidence.

Others criticized the use of morphine milligram equivalents (MMEs) in determining the appropriate dosing of different opioids. As Fudin and others have argued, MME dosing was designed in an attempt to examine opioids with similar analgesic effects and should not be used to determine an exact mathematical dosing conversion.

“MME IS NOT A STANDARDIZE CLINICAL METRIC”

The pharmacology and unique properties of each opioid and patient individuality must be considered when a therapeutic opioid conversion is contemplated. Conversion should not simply rely on a mathematical formula embedded within the CDC calculator software.

Furthermore, the current calculation for methadone employed by the calculator could allow for potentially dangerous conversions. This is especially problematic, considering this calculator is intended to target nonspecialist general practitioners. We expect a higher level of scientific accuracy and integrity from an agency entrusted to protect citizens’ health and welfare.

Recognizing the controversy surrounding MMEs, in August 2021, the FDA held a “public workshop” entitled “Morphine Milligram Equivalents: Current Applications and Knowledge Gaps, Research Opportunities, and Future Directions.” The workshop’s stated purpose was to “provide an understanding of the science and data underlying existing MME calculations for opioid analgesics, discussing the gaps in these data, and discussing future directions to refine and improve the scientific basis of MME applications.”

DONATE LEGAL DEFENSE

OR SEND

$10, $15, $20, $25,$50, $75, 175, $500. OR MORE TO CASH APP:$docnorm

ZELLE 3135103378 or Donate to the “Pharmacist For Healthcare Legal Defense Fund,

NABARUN DASGUPTA et al.DOES THE MATH

During the workshop, Nabarun Dasgupta of the University of North Carolina Injury Prevention Research Center presented research stating: “Contrary to conventional wisdom, conversion values are not based on pharmacologic properties. Instead, they arose 60 years ago from small single-dose clinical studies in post-operative or cancer populations with pain score outcomes; toxicologic effects (e.g., respiratory depression) were not evaluated.”

The research concluded: “The overlooked inconsistency among daily MME definitions revealed by our study calls into question the clinical validity of a single numerical risk threshold. . . . Our findings call into question state laws and third-party payer MME threshold mandates. Without harmonization, the scientific basis for these mandates may need to be revisited.”86 Some critics consider the use of MMEs to be “junk science.”

Nevertheless, many states implemented statutory or regulatory limits on the dose (in MMEs) and number of opioids that may be prescribed to patients in acute, chronic, and postoperative situations, respectively, and they encouraged policies promoting the rapid or abrupt tapering of chronic pain patients off the opioid therapies on which they had been maintained long-term.

In 2018, Oregon proposed a mandatory reduction to zero opioids calculation for methadone employed by the calculator could allow for potentially dangerous conversions. This is especially problematic, considering this calculator is intended to target nonspecialist general practitioners. We expect a higher level of scientific accuracy and integrity from an agency entrusted to protect citizens’ health and welfare in Medicaid patients over 12 months. The state reversed itself after receiving fierce criticism from pain management and addiction specialists.

 

for now, youarewithinthenorms.com

 

 

REBECCA DELFINO: WHO IS SHE AND WHY IS MS. DELFINO ONE OF AMERICA’S MOST DANGEROUS LAW PROFESSORS IN PAIN MANAGEMENT HEALTHCARE POLICY, PART-1

Many of Delfino’s assertions regarding the evolution of drug regulation in the United States are either inaccurate or lacking nuance. For example, the Article states that the Opium Exclusion Act of 1909 “was the first government regulation of opioids.” Delfino, supra note 4, at 354. While this law was the first federal prohibition on opiate use, Congress had previously regulated opiate availability through taxation and tariffs, see Audrey Redford & Benjamin Powell, Dynamics of Intervention in the War on Drugs:

 

WARNING!!! WARNING!!! WARNING!!! TO ALL PROVIDERS AND PATIENTS: MEET REBECCA DELFINO, AMERICA’S MOST DANGEROUS LAW PROFESSOR AND PAIN HEALTHCARE POLICY MAKER; Part-1

 

JUSTICE FOR DR. RANDY LAMARTINIERE, MD…FREE DR. RANDY NOW!!!!

Dr. Randy Lamartiniere, MD, did everything by the book, as we all do. He monitored their care with drug screens and conducted reevaluations every three months for his very reasonable standard medical fee without any added charges for pain management. And got 15 years Fed Prison by one of America’s most Corrupt Federal Judge in America’s Most Corrupt Judicial Circuit. “No Justice, No Peace…Free Dr. Randy Now!!!

 

ANOTHER SAD DAY IN MEDICINE: CORRUPT FEDERAL JUDGE BRIAN JACKSON GIVES 15 YEARS OF FEDERAL PRISON TIME TO DR. RANDY LAMARTINERE, MD, FOR PRACTICING MEDICINE!!! **!!PLATO HEALTH INTEGRITY’S VENDOR FRAUD!!!**

 

DR. SHIVA AKULA, MD LOVES AMERICA IS AN HERO, SAVED LIVES DURING COVID-19 PANDEMIC, HOWEVER!?..

DR. SHIVA AKULA, MD “AN AMERICAN HERO:” THE DEPARTMENT OF JUSTICE TARGETING OF SUCCESS, AND FACING A REALITY OF, ‘PRACTICING MEDICINE WHILE BROWN’ IN AMERICA’

The lawsuit details the method of the conspiracy and how the criminal indictment is purposed to eliminate Dr. Akula from the American healthcare market to permit his competitors to seize his business and personal assets:“ The indictment and subsequent prosecution were a consequence of a conspiracy concocted by Defendants Passages, Anderson, and co-conspirator William Cassidy, Esq, all of whom stood to profit at the expense of Plaintiff Akula, through respectively, increased market share by eliminating Akula and seizing his business assets, a ‘whistleblower’ fee, and legal fees for Plaintiff Akula’s criminal defense.”

AMERICA HAS BEEN BAMBOOZLED BY BAMBOO HEALTH (PDMP) NARXCARE SOFTWARE

Norman J. Clement RPh., DDS, MS; BAMBOOZLED BY BAMBOO HEALTH: Our group and writers of youarewithinthenorms.com and Pronto Pharmacy LLC, Tampa Fl are in full support of the Citizen Petition Submitted by the Center for U.S. Policy to request the Commissioner of the U.S. Food and Drug Administration (“FDA”) to deem the Bamboo Health (“Bamboo”) NarxCare software a misbranded device and take administrative action to prevent serious, adverse health consequences and death. We further demand the immediate removing this dangerous software from all Healthcare Systems.

 

LETTER TO FDA: IN SUPPORT OF CENTER FOR U.S. POLICY PETITION FOR IMMEDIATE TERMINATION OF DEA’s NARXCARE AND PDMP SYSTEMS AS MISBRANDED, DANGEROUS AND “CAUSING DEATHS”

 

“FROM COPS TO CLINICIANS” DEA’s CONTROL REGISTRATION “A SWORD OF DAMOCLES,”

THE DEA BIG LIE! While the DEA has consistently emphasized and supported the prescriptive authority of an individual practitioner under the CSA to administer, dispense, and prescribe controlled substances for the legitimate treatment of pain within acceptable medical standards. This is outlined in the DEA’s policy statement published in the Federal Register (FR) on September 6, 2006, titled, Dispensing Controlled Substances for the Treatment of Pain, 71 FR 52716. {A copy is enclosed for your convenience.}”
This statement put out by DEA headquarter is one big lie!!!

 

“FROM COPS TO CLINICIANS” DEA’s CONTROL REGISTRATION “A SWORD OF DAMOCLES,” MOVING NARCOTIC REGISTRATION TO THE OFFICE OF THE UNITED STATES SURGEON GENERAL

 

FROM COPS TO CLINICIANS: The PDMP system started as a law enforcement tool but “has migrated to a Clinical decision Support Focus

Senator Warnock: “From Cops to Clinicians,” It is past time to move the mission of medical Control Substance Registration and licensing from Cops to clinicians from the Department of Justice, specifically the United States Drug Enforcement Administration (DEA), to the Office of the United States Surgeon General. Law enforcement has absolutely no business in the practice of medicine and the dictation of medical protocols.

 

DEAR SENATOR RAPHAEL WARNOCK: DEA’s (A-I) PRESCRIPTION DRUG MONITORING PROGRAMS NARXCARE SOFTWARE TO BE MISBRANDED, CAUSING DEATH: “A MAJOR CONTRIBUTING FACTOR,” IN MAY 3RD ATLANTA’s VA MASS SHOOTINGS!!!

 

THE OPIOID WAR: A FRAUDULENT GOVERNMENT-CREATED SCANDAL THRU PROSECUTORIAL FRAUD AND JUDICIAL ABUSE

Dr. Neil Anand, MD: My mission includes promoting government transparency and accountability by gathering official information, analyzing it, and disseminating it through reports, press releases, and/or other media, including social media platforms, all to educate the public. All the records that my FOIA request from USDOJ will eventually produce will be made publicly available on the Internet for citizens, journalists, and scholars to review and use. USDOJ is an agency of the federal government within the meaning of 5 U.S.C. § 552(f) and has possession and control of the records that I seek.

 

UPDATE: DOJ-DEA DOCUMENTS OBTAIN UNDER FOIA DEMONSTRATE THE OPIOID WAR AGAINST DOCTORS AND PATIENTS AMOUNTS TO MASSIVE PROSECUTORIAL FRAUD AND JUDICIAL ABUSE: THE STORY OF DR. NEIL ANAND MD., OPPOSING INJUSTICE (THE RAW DATA IS IN)

 

DEA’s PDMP “NARXCHECK” SYSTEMS USED BY NEARLY ALL HOSPITAL AND PHARMACIES TO BE MISBRANDED, DANGER TO HEALTHCARE

FDA is “responsible for protecting the public health by ensuring the safety, efficacy, and security of . . . medical devices . . .”74 A “device” subject to FDA regulation includes “an instrument . . . , machine . . . , or other similar or related article . . . which is . . . intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease . . .”

 

STUDY BY CENTER FOR UNITED STATES POLICY SHOWS DEA’s PDMP “NARXCHECK” SYSTEMS USED BY NEARLY ALL HOSPITAL AND PHARMACIES TO BE MISBRANDED, DANGER TO HEALTHCARE, and USE MUST BE SUSPENDED IMMEDIATELY BY FDA